Goodwin

We are a firm of insiders driving client value through deep industry knowledge, legal excellence, and business advisory expertise.

[Goodwin @goodwinlaw]

Connect with the innovators shaping the future of chemistry. Goodwin is sponsoring ACS Fall 2026 in Chicago, bringing together entrepreneurs, investors, researchers, and industry leaders transforming scientific discoveries into real-world impact.

Goodwin team members will participate in various events including:

• Monday, August 24 | 2 pm CT: Jonathan Ng and Yoko J. Bian, PhD will participate in the interdisciplinary panel “Wearable Sensors: Chemistry-Powered Technologies for Better Health, Fitness, and Security” in Room W190a at McCormick Place.

• Tuesday, August 25 | 12:30 pm CT: Gabriel Ferrante will participate in the debate “Should Patent Law Recognize Non-Human Inventors?” at the Expo Theatre. Goodwin does not endorse either position presented in the debate.

• Wednesday, August 26 | 12–2 pm CT: Goodwin partners Eric Romeo and Olivia D. Uitto, Ph.D, J.D. will join Northwestern University’s Karl Scheidt and Lindsay Stolzenburg for the Start-Up Community program panel and networking reception, “Intellectual Property: The Most Valuable ‘Protecting Group’ for Your Chemical Business,” in Room W190a at McCormick Place.

Save your seat today: https://t.co/sftZVcJpaL

#ACSFall2026 #IntellectualProperty #Startups #Technology #Innovation #Chemistry #Science

[Goodwin @goodwinlaw]

As the Senate continues to consider the CLARITY Act, there are a number of reasons why this statutory implementation would better support and facilitate strong, secure and safe growth of crypto projects better than only relying on SEC, CFTC and agency guidance for strong growth of crypto projects.

In our recent webinar, Defining the Future of Digital Assets: The CLARITY Act and Key Industry Developments, Goodwin's Karen Ubell discusses the framework's potential benefits, including greater certainty for secondary market trading, a key differentiation from SEC guidance that will be important, if CLARITY passes, to ensuring the liquidity and transferability necessary for crypto networks to grow and thrive.

Watch the full discussion here: https://t.co/UOZQzArIt7

Karen also provided additional analysis of the differences between the legislative proposal and agency guidance in her Law360 article: https://t.co/jy4umv5yDH

#DigitalAssets #Blockchain

[Goodwin @goodwinlaw]

How much of a 510(k) can AI safely touch? We are hosting a closed-door MedTech regulatory breakfast with Matrix One at our Redwood City office on Thursday, August 20.

Conversation will focus on AI for regulatory affairs, a practical playbook for MedTech teams: where AI genuinely helps in device submissions and where it does not, the legal and compliance questions it raises, and keeping the design history file audit-ready. At the table will be Steven Tjoe of our Life Sciences Regulatory & Compliance group and Farhan Shahab of Moximed.

Coffee and breakfast will begin at 8:00 AM. Free to attend, spaces limited.

Register: https://t.co/7rI7UJY1C5

#LifeSciences #Healthcare #Biotech

[Goodwin @goodwinlaw]

Congratulations to Draig Therapeutics on the closing of an oversubscribed $65 million Series B financing.

Draig Therapeutics is a clinical-stage biopharmaceutical company focused on developing transformative, best-in-class neuropsychiatric therapies.

The Goodwin Life Sciences team, led by Kenny Walker-Durrant, Kingsley Taft, Hattie Muncey, and Claudia Baldelli, was pleased to advise.

For more on the deal: https://t.co/J0n5bJSjXW

#LifeSciences

[Michelle Lee @michellearning]

The future of bio is powered by faster data

Introducing the Medra AI Experimentalist: an agent that turns goals into experimental designs, learns from every result, and develops the next assay

Excited to collaborate with @DARPA and @NVIDIAHealth on the future of science

[Hivemind @HivemindCap]

Some of the most important breakthroughs in AI and frontier technology never make it beyond the lab.

Federal research funding is declining. Corporate funding often comes with IP concessions. And traditional venture capital typically enters the picture long after the most critical research has been done. Too often, groundbreaking ideas are left without the resources needed to reach the next stage.

That's why we're excited to launch darkmatter lab in partnership with @UCBerkeley , with support from @googlecloud , @GundersonLaw , and @goodwinlaw.

Built for researchers before a company exists, darkmatter lab provides at least $1 million in resources per project, including research funding, compute credits, legal support, and operational expertise.

We're starting with AI and blockchain, supporting work in areas like AI infrastructure, agentic systems, cybersecurity, cryptography, compute optimization, and decentralized technologies.

This is the cornerstone of Hivemind's upcoming venture fund and a new approach to helping transformative research make the leap from academia into the real world.

Learn more: https://t.co/2Y2SYfPE5D

[Glasswing Ventures @GlasswingVC]

What makes an AI company defensible?

We're unpacking it live at Defensible AI during #BOSTechWeek with @HSBC, @goodwinlaw, and @Techstars.

Featuring @rudina11, David Sabow, @ADawesar75992, @jonathanjeffrey, and more!

May 27th, 9am | Glasswing Office

RSVP: https://t.co/chxwo8Edn9

[Techstars @Techstars]

We're headed to Boston Tech Week! ⭐

If you're building, investing, or just curious about what's next in enterprise AI, this one's worth blocking off your calendar for.

We're teaming up with @GlasswingVC, @goodwinlaw, and @HSBC for conversation on what actually makes AI products stick inside the enterprise.

🛡️ Defensible AI: Building Trust and Resilience in the Enterprise
📆 May 27 at 9:00–11:30am ET
🔗 https://t.co/z08kh6NLsM

Join us at @Techweek_!

[The Deal by S&P Global @TheDealNewsroom]

Listen to the latest Activist Investing Today #podcast with @rorol, where @goodwinlaw partner Leonard Wood discusses #activism trends in REITs and biotech and evolving settlement dynamics. https://t.co/CuLQtYIJRM

[Goodwin @goodwinlaw]

@michellearning Congratulations to the Medra team - this is huge. 🤖

[Goodwin @goodwinlaw]

Congratulations to our friends at @HightouchData for raising the standard on AI-generated creative at scale with their launch of Ad Studio.

[Tejas Manohar @tejasmanohar]

every marketer I talk to is banging their heads against a wall right now

"how do I get AI ads to not be... so bad?"

we just launched Ad Studio @HightouchData

��� we know your brand
✅ we know your existing creative
✅ we know what works in your ads

ps: you can edit without re-prompting

[Michelle Lee @michellearning]

The next industrial revolution isn’t software. It’s science.

[GC AI @gcai]

The #2026GCAISummit afternoon sessions kick off with M&A Greatness.

Larry Chu, Strategic Advisor, Global Co-chair of Global M&A of @goodwinlaw on why AI is turning M&A deal speed into a strategic advantage, and why the real asset is still people + know-how.

[Ruby Gadelrab @DivaBiotech]

I loving watching my good friend Deepa Rich from @goodwinlaw interview @ChelseaClinton at #JPM2026

[Goodwin @goodwinlaw]

What does legal transformation look like inside a large, established institution—and what happens when you don’t innovate at the right moment?

Keir Gumbs, Chief Legal Officer at Edward Jones, brings a rare 360° view of the legal and regulatory landscape, shaped by experience across major institutions and government. In this episode of Pearls On, Gloves Off, he shares with Mary O’Carroll what it takes to modernize a legal function from within: reshaping how legal, compliance, and risk partner with the business and leading with an “enable first” mindset.

One big takeaway: the job isn’t just protecting the enterprise. It’s enabling it to grow—responsibly.

A timely listen for anyone navigating transformation, governance, and the future of firm partnerships. 🎧

Apple: https://t.co/wORtmNm0qw
Spotify: https://t.co/F0MZKCnRPG

#LegalTransformation #Leadership #LegalOps #Governance

[Goodwin @goodwinlaw]

Announcing a special guest speaker at the Goodwin + KPMG Symposium @ J.P. Morgan.

We’re excited to announce Namandje Bumpus, PhD—strategic advisor, nationally recognized biomedical scientist, and former Principal Deputy Commissioner of the FDA—as a featured speaker.

Dr. Bumpus brings deep experience at the intersection of regulatory science, public health policy, and life sciences innovation. She previously served as the FDA’s second-in-command and now, through Bumpus Advising, partners with organizations on regulatory strategy and scientific engagement. Her work has been recognized at the highest levels of science and public service, including election to the National Academy of Medicine.

📅 January 14, 2026
🕒 PM PT
💬 Fireside Chat: Goodwin and KPMG Chat with Dr. Bumpus on Regulatory & Policy Outlook

Explore the agenda and register to join conversations with leaders across life sciences and healthcare: https://t.co/6gUsBREOvt

#LifeSciences #Healthcare #JPM2026